Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Veronika Wertzova"'
Autor:
Veronika Wertzova, Jiri Beran, Petr Tichy, Diane Kervyn, Sherine Kuriyakose, Maarten Leyssen, Jeanne-Marie Jacquet, Lenka Hobzova
Publikováno v:
Vaccine. 28:5993-5997
300 adolescents aged 12-15 years were randomised (1:1) into two groups to compare the long-term (10 years) immunogenicity profile of two doses of an Adult formulation [Group HAB_2D: 150; 0-6 months] vs. three doses of a Paediatric formulation [Group
Autor:
Maarten Leyssen, Jiri Beran, Veronika Wertzova, Murielle Surquin, Sophie Houard, Sherine Kuriyakose, Lenka Hobzova
HB-AS 02 is an investigational adjuvanted hepatitis B virus (HBV) vaccine for potential use in patients with renal insufficiency and other immunocompromised individuals. In this Phase III lot-to-lot consistency study, 450 healthy adult volunteers who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73b7447baeabd8740f364d6071ec057a
https://europepmc.org/articles/PMC3322521/
https://europepmc.org/articles/PMC3322521/
Autor:
Veronika Wertzova, Jeanne-Marie Devaster, Pascale Van Belle, Eva Kaliskova, Bruce L. Innis, Helena Jirincova, Jiří Beran, Martina Havlíčková, Jiří Havlík, Karel Honegr, Varsha K. Jain
Publikováno v:
BMC Infectious Diseases, Vol 9, Iss 1, p 2 (2009)
BMC Infectious Diseases
BMC Infectious Diseases
Background Our aim was to determine the efficacy of a trivalent inactivated split virus influenza vaccine (TIV) against culture-confirmed influenza A and/or B in adults 18 to 64 years of age during the 2005/2006 season in the Czech Republic. Methods